Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGCG supplementation in Multiple System Atrophy
DRKS00005610Phase 3Completed
- Sponsor
- LMU Klinikum
- Start
- Jan 2014
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multiple system atrophy (MSA) comparing EGCG 1200 mg/day with Placebo (2 arms). Started Jan 2014; status: completed.
02
Drugs
epigallocatechin gallate
03
Conditions
multiple system atrophy (MSA)
Beyond the preview
Go deeper on DRKS00005610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00005610.